Audit report of the Board of Regents for the year ended June 30, 2013

Audit report of the Board of Regents for the year ended June 30, 2013

Appropriateness of therapy for active Crohn's disease: results of a multidisciplinary International Expert Panel (EPACT II)

Introduction: The development of novel therapies and the increasing number of trials testing management strategies for luminal Crohn's disease (CD) have not filled all the gaps in our knowledge. Thus, in clinical practice, many decisions for CD patients need to be taken without high quality evidence. For this reason, a multidisciplinary European expert panel followed the RAND method to develop explicit criteria for the management of individual patients with active, steroid-dependent (ST-D) and steroid-refractory (ST-R) CD. Methods: Twelve international experts convened in Geneva, Switzerland in December 2007, to rate explicit clinical scenarios, corresponding to real daily practice, on a 9-point scale according to the literature evidence and their own expertise. Median ratings were stratified into three categories: appropriate (7-9), uncertain (4-6) and inappropriate (1-3). Results: Overall, panelists rated 296 indications pertaining to mild-to-moderate, severe, ST-D, and ST-R CD. In anti-TNF naïve patients, budesonide and prednisone were found appropriate for mildmoderate CD, and infliximab (IFX) when those had previously failed or had not been tolerated. In patients with prior success with IFX, this drug with or without co-administration of a thiopurine analog was favored. Other anti-TNFs were appropriate in case of intolerance or resistance to IFX. High doses steroids, IFX or adalimumab were appropriate in severe active CD. Among 105 indications for ST-D or ST-R disease, the panel considered appropriate the thiopurine analogs, methotrexate, IFX, adalimumab and surgery for limited resection, depending on the outcome of prior therapies. Anti-TNFs were generally considered appropriate in ST-R. Conclusion: Steroids, including budesonide for mild-to-moderate CD, remain first-line therapies in active luminal CD. Anti-TNFs, in particular IFX with respect to the amount of available evidence, remain second-line for most indications. Thiopurine analogs are preferred to anti-TNFs when steroids are not appropriate, except when anti-TNFs were previously successful. These recommendations are available online (www.epact.ch). A prospective evaluation of these criteria in a large database in Switzerland in underway to validate these criteria.

Iowa Board of Nursing Newsletter, August, September, October, 2014 Vol. 33, no. 3

Newsletter produced by the Iowa Board of Nursing for nurses to keep them informed to CE classes, renewals, board meetings, etc. Produced 4 times a year. Also known as Nursing Newsletter.

Audit report on the Iowa Petroleum Underground Storage Tank Board for the year ended June 30, 2013

Audit report on the Iowa Petroleum Underground Storage Tank Board for the year ended June 30, 2013

Iowa Flood Mitigation Board Annual Report, 2013

The Iowa Flood Mitigation Program is created within Code of Iowa, Chapter 418. The Program seeks to provide funds for flood mitigation projects that otherwise would not be funded. The Flood Mitigation Board is responsible for the implementation Code of Iowa Chapter 418. The membership of the Board is comprised of four voting public members appointed by the Governor, five voting members representing state agencies, and four non-voting ex-officio members of the legislature.

Audit report on the Public Employment Relations Board for the year ended June 30, 2013

Audit report on the Public Employment Relations Board for the year ended June 30, 2013

Audit report on the National Deaf-Blind Equipment Distribution Program administered by the Iowa Utilities Board Division of the Iowa Department of Commerce for the year ended June 30, 2013

Audit report on the National Deaf-Blind Equipment Distribution Program administered by the Iowa Utilities Board Division of the Iowa Department of Commerce for the year ended June 30, 2013

Audit report on the National Deaf-Blind Equipment Distribution Program administered by the Iowa Utilities Board Division of the Iowa Department of Commerce for the year ended June 30, 2014

Audit report on the National Deaf-Blind Equipment Distribution Program administered by the Iowa Utilities Board Division of the Iowa Department of Commerce for the year ended June 30, 2014

Remsen source water protection project : agreement no. 8025-015 between the Iowa Watershed Improvement Review Board and the City of Remsen final report.

This final report to the Iowa Watershed Improvement Review Board by the City of Remsen Utilities consists of accomplishments made by the Remsen Utilities as per this agreement. The City of Remsen Utilities did in fact purchase approximately 27 acres of land lying upstream of the city’s water well field. The land was purchased from Mr. Larry Rodesch and Mr. Rich Harpenau for the purpose of removing nitrates from Remsen’s water source and establishing native prairie grasses to assist in this removal.

Audit report on the Iowa Corn Promotion Board for the years ended August 31, 2014 and 2013

Audit report on the Iowa Corn Promotion Board for the years ended August 31, 2014 and 2013

Iowa Board of Pharmacy News, February 2012

The Iowa Board of Pharmacy News is published by the Iowa Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug law.

Iowa Board of Pharmacy News, March 2013

The Iowa Board of Pharmacy News is published by the Iowa Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug law.

Iowa Board of Pharmacy News, March 2014

The Iowa Board of Pharmacy News is published by the Iowa Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug law.

Iowa Board of Pharmacy News, June 2009

The Iowa Board of Pharmacy News is published by the Iowa Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug law.

Iowa Board of Pharmacy News, June 2009

The Iowa Board of Pharmacy News is published by the Iowa Board of Pharmacy and the National Association of Boards of Pharmacy Foundation, Inc, to promote compliance of pharmacy and drug law.